EUVIMEDEUVIMED entdecken
Crossref

Hemoglobin Switching, Sickle-Cell Therapy, and the Future of Gene Editing

Linda Liu

Harvard Undergraduate Health Policy Review · 2026 · 26 (1)

DOI: 10.56927/894668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Harvard Undergraduate Health Policy Review, 2026. Verfasst von Linda Liu.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liu, L. (2026). Hemoglobin Switching, Sickle-Cell Therapy, and the Future of Gene Editing. Harvard Undergraduate Health Policy Review, 26(1). https://doi.org/10.56927/894668

Vancouver

Liu L. Hemoglobin Switching, Sickle-Cell Therapy, and the Future of Gene Editing. Harvard Undergraduate Health Policy Review. 2026;26(1). doi:10.56927/894668

BibTeX
@article{Liu2026,
  author = {Liu, Linda},
  title = {Hemoglobin Switching, Sickle-Cell Therapy, and the Future of Gene Editing},
  journal = {Harvard Undergraduate Health Policy Review},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.56927/894668}
}
Kostenlos starten →